This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,300 
2 out of 5,026 
Years Active: 2020-2023
Title: Innovations by Inventor Amit Garg
Introduction
Amit Garg is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of cancer treatment through his innovative work on HER2 antibody formulations. With a total of 2 patents, his inventions are paving the way for advancements in medical therapies.
Latest Patents
Amit Garg's latest patents focus on subcutaneous HER2 antibody formulations. These fixed-dose formulations are designed for subcutaneous administration and are intended for use in the treatment of cancer. The formulations include fixed-dose subcutaneous formulations of pertuzumab, as well as subcutaneous co-formulations of pertuzumab and trastuzumab. These innovations aim to enhance the efficacy and convenience of cancer treatments.
Career Highlights
Throughout his career, Amit Garg has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Amit has collaborated with talented professionals such as Jennifer Eng-Wong and Whitney Kirschbrown. These partnerships have played a crucial role in advancing his research and development efforts.
Conclusion
Amit Garg's contributions to the field of cancer treatment through his innovative HER2 antibody formulations highlight his dedication to improving patient outcomes. His work exemplifies the impact of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile